Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022
Consistent with previous studies, we found an association between TTS and receiving a first dose of AZD1222. There were no associations of TTS with AZD1222 second dose and BNT162b2 first or second doses.
Authors
- Simon de Lusignan (ORCID: https://orcid.org/0000-0002-8553-2641)
- Richard Hobbs (ORCID: https://orcid.org/0000-0001-7976-7172)
- Lisa Mather (ORCID: https://orcid.org/0000-0002-3901-4579)
- William A. Hinton
- Bernardo Meza-Torres (ORCID: https://orcid.org/0000-0001-6551-5484)
- Gavin Jamie (ORCID: https://orcid.org/0000-0001-9147-7784)
- Anna Forbes (ORCID: https://orcid.org/0000-0001-7860-3782)
- Xuejuan Fan (ORCID: https://orcid.org/0000-0002-0165-8344)
- Xinchun Gu (ORCID: https://orcid.org/0000-0002-2202-6792)
- Sneha Anand (ORCID: https://orcid.org/0000-0002-0538-3974)
- Debasish Kar (ORCID: https://orcid.org/0000-0002-1524-1312)
- José M Ordóñez-Mena (ORCID: https://orcid.org/0000-0002-8965-104X)
- Rachel Byford (ORCID: https://orcid.org/0000-0002-4792-8995)
- Filipa Ferreira (ORCID: https://orcid.org/0000-0003-2555-4176)
- Rashmi Wimalaratna (ORCID: https://orcid.org/0009-0000-3244-9679)
- Mark Joy
- D. Mark Layton (ORCID: https://orcid.org/0009-0008-2080-044X)
- Andrew G. Lee
Institutions
- AstraZeneca (United Kingdom) (GB)
- University of Hertfordshire (GB)
- University of Oxford (GB)
- AstraZeneca (Netherlands) (NL)
- AstraZeneca (Finland) (FI)
- AstraZeneca (Sweden) (SE)
- University of Plymouth (GB)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1016/j.ijid.2025.108289
- Citations
- 1
- Primary Topic
- Heparin-Induced Thrombocytopenia and Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 2.01